Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
| DRUGNAME | PT | EventCount |
|---|---|---|
| GEMCITABINE | General physical health deterioration | 18 |
| GEMCITABINE | Neutrophil count decreased | 18 |
| GEMCITABINE | Rash | 18 |
| GEMCITABINE | Urinary tract infection | 18 |
| GEMCITABINE HYDROCHLORIDE. | Ascites | 18 |
| GEMCITABINE | Alanine aminotransferase increased | 17 |
| GEMCITABINE | Bone marrow failure | 17 |
| GEMCITABINE | Infection | 17 |
| GEMCITABINE HYDROCHLORIDE. | Dehydration | 17 |
| GEMCITABINE HYDROCHLORIDE. | Device occlusion | 17 |
| GEMCITABINE HYDROCHLORIDE. | Disease progression | 17 |
| GEMCITABINE HYDROCHLORIDE. | Syncope | 17 |
| GEMCITABINE | Dyspnoea exertional | 16 |
| GEMCITABINE | Gastrointestinal haemorrhage | 16 |
| GEMCITABINE | Atrial fibrillation | 15 |
| GEMCITABINE | Cholangitis acute | 15 |
| GEMCITABINE | Mucosal inflammation | 15 |
| GEMCITABINE HYDROCHLORIDE. | Biliary tract infection | 15 |
| GEMCITABINE | Cholangitis | 14 |
| GEMCITABINE | Hypokalaemia | 14 |
Total Records: 1,060 Number of Pages: 53